Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation

Pensionsversicherungsanstalt

Status

Completed

Conditions

Ulcerative Colitis

Crohn Disease

Treatments

Behavioral: Multimodal Rehabilitation

Study type

Observational

Funder types

Other

Identifiers

NCT05500040

0008-CED

Details and patient eligibility

About

For many people affected by inflammatory bowel disease (IBD), their quality of life and their ability to participate in their professional and social lives are severely restricted. Rehabilitation measures based on the biopsychosocial ICF model aim to support the restoration of these abilities. Physiological parameters (e.g. biomarkers) as well as patient-reported outcomes (PROs) can be used to assess the success of ICF-based rehabilitation measures and to optimize them. A suitable biomarker to monitor inflammation in IBD patients is faecal calprotectin. In addition, PROs that support patients in providing information, for example on their health-related quality of life or on their subjective ability to work, can provide information on the individual social and occupational participation ability of the patients. The aim of this project is to investigate changes in a biomarker (calprotectin) as well as in selected PROs after a three-week inpatient phase II rehabilitation.

Enrollment

226 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria